Patient information centre

Liver health information for Australian patients

Plain-English guides on fatty liver, liver fibrosis testing, what a FibroScan involves, and how to find a liver elastography clinic near you.

Clinic finder

Find a liver elastography clinic near you

Search for accredited clinics offering guided liver elastography across Australia. No referral required at most locations — you can request an appointment directly.

Search clinics

Patient guides

Plain-English explanations of liver tests, what they measure, how they work, and what your results mean — written for patients, not clinicians.

Condition explained

What is MASH? The condition your doctor may have mentioned

MASH (Metabolic dysfunction-Associated SteatoHepatitis) is the advanced form of fatty liver disease where the liver is inflamed and beginning to scar. It affects millions of Australians — most of whom have no symptoms. Learn what it means, who is at risk, and how it is diagnosed.

Read the plain-English guide
37%
of Australian adults have MAFLD (AusDiab study)
500K+
Australians estimated to have significant liver fibrosis
No symptoms
Most patients with MAFLD have no symptoms until late stages
2 min scan
A guided elastography scan takes approximately 2 minutes

News & articles

7 Apr 2026

FibroScan Limitations: What Australian Clinics Need to Know | Elastography Australia

FibroScan is the market-leading liver elastography device, but it has documented limitations in obese patients, workflow efficiency, and operator guidance. Here's what the evidence shows.

Read article

6 Apr 2026

Portable Liver Elastography for Regional Australia | Elastography Australia

Regional and rural Australian practices face a liver disease access gap. Guided elastography systems are changing that — here's what regional clinics need to know.

Read article

5 Apr 2026

Type 2 Diabetes and MAFLD: Why Every Diabetic Patient Needs Liver Assessment | Elastography Australia

Type 2 diabetes and MAFLD overlap in up to two-thirds of cases. Here's the evidence-based screening pathway for Australian GPs managing diabetic patients with liver risk.

Read article

4 Apr 2026

Hepatitis B and Liver Elastography: 2024 WHO Guidelines Explained | Elastography Australia

The 2024 WHO hepatitis B guidelines updated elastography thresholds for treatment decisions. Here's what Australian clinicians need to know about using liver stiffness measurement in chronic HBV management.

Read article

3 Apr 2026

Liver Disease in Australia: 2026 Statistics and Trends | Elastography Australia

Key statistics on liver disease burden in Australia — MAFLD prevalence, liver cancer rates, screening gaps, and what the numbers mean for clinical practice.

Read article

2 Apr 2026

Resmetirom for MASH: What Australian Clinicians Need to Know | Elastography Australia

Resmetirom (Rezdiffra) is the first approved MASH therapy globally. Here's what Australian clinicians need to know about staging, monitoring, and why elastography is central to its use.

Read article

How to get a liver elastography test

Getting a liver stiffness test in Australia is straightforward. Here is what the process looks like from start to finish.

1

Talk to your GP

Ask your GP about liver fibrosis screening — especially if you have type 2 diabetes, fatty liver on a prior scan, or a high BMI.

2

Get a FIB-4 blood test

Your GP can calculate a FIB-4 score from a standard blood test. An indeterminate result (1.3–2.67) means elastography is the recommended next step.

3

Book a liver scan

Use our clinic finder to locate an accredited practice near you offering guided liver elastography. Most appointments take under 30 minutes.

4

Get your result

Your kPa stiffness result is typically available immediately. Your doctor uses it to guide treatment and monitoring decisions.

Medical disclaimer: All content on this page is educational and is not intended as medical advice. Diagnosis and treatment decisions must be made by a qualified healthcare professional. If you have concerns about your liver health, speak with your GP.